Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Andrew Avins and Nicola Klein.
Andrew Avins
Connection Strength
5.851
Nicola Klein
  1. A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age. Vaccine. 2021 Sep 07; 39(38):5428-5435.
    View in: PubMed
    Score: 0.395
  2. Vaccine safety in special populations. Hum Vaccin. 2011 Feb; 7(2):269-71.
    View in: PubMed
    Score: 0.383
  3. Antibody persistence and booster response following MenACWY-CRM vaccination in children as assessed by two different assay methods. Vaccine. 2019 07 26; 37(32):4460-4467.
    View in: PubMed
    Score: 0.343
  4. Long term risk of developing type 1 diabetes after HPV vaccination in males and females. Vaccine. 2019 Mar 28; 37(14):1938-1944.
    View in: PubMed
    Score: 0.335
  5. Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study. Vaccine. 2018 04 19; 36(17):2356-2363.
    View in: PubMed
    Score: 0.314
  6. Risk factors and familial clustering for fever 7-10days after the first dose of measles vaccines. Vaccine. 2017 03 14; 35(12):1615-1621.
    View in: PubMed
    Score: 0.291
  7. Waning Tdap Effectiveness in Adolescents. Pediatrics. 2016 Mar; 137(3):e20153326.
    View in: PubMed
    Score: 0.271
  8. Safety of measles-containing vaccines in 1-year-old children. Pediatrics. 2015 Feb; 135(2):e321-9.
    View in: PubMed
    Score: 0.251
  9. One or two doses of quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine is immunogenic in 9- to 12-month-old children. Pediatr Infect Dis J. 2013 Jul; 32(7):760-7.
    View in: PubMed
    Score: 0.226
  10. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013 Jun; 131(6):e1716-22.
    View in: PubMed
    Score: 0.224
  11. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.
    View in: PubMed
    Score: 0.214
  12. Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers. Vaccine. 2012 Jun 06; 30(26):3929-36.
    View in: PubMed
    Score: 0.208
  13. Measles-containing vaccines and febrile seizures in children age 4 to 6 years. Pediatrics. 2012 May; 129(5):809-14.
    View in: PubMed
    Score: 0.207
  14. Safety and immunogenicity of a novel quadrivalent meningococcal CRM-conjugate vaccine given concomitantly with routine vaccinations in infants. Pediatr Infect Dis J. 2012 Jan; 31(1):64-71.
    View in: PubMed
    Score: 0.204
  15. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children. Vaccine. 2012 Jan 11; 30(3):668-74.
    View in: PubMed
    Score: 0.202
  16. Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization. Pediatr Infect Dis J. 2010 Jul; 29(7):613-7.
    View in: PubMed
    Score: 0.184
  17. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics. 2010 Jul; 126(1):e1-8.
    View in: PubMed
    Score: 0.184
  18. Preterm infants' T cell responses to inactivated poliovirus vaccine. J Infect Dis. 2010 Jan 15; 201(2):214-22.
    View in: PubMed
    Score: 0.178
  19. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine. 2010 Jan 22; 28(4):1062-8.
    View in: PubMed
    Score: 0.176
  20. Long-term effectiveness of zoster vaccine live for postherpetic neuralgia prevention. Vaccine. 2019 08 23; 37(36):5422-5427.
    View in: PubMed
    Score: 0.172
  21. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008 Mar; 121(3):463-9.
    View in: PubMed
    Score: 0.156
  22. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants. Vaccine. 2017 06 16; 35(28):3564-3574.
    View in: PubMed
    Score: 0.148
  23. Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine. Vaccine. 2017 06 08; 35(26):3395-3400.
    View in: PubMed
    Score: 0.148
  24. A role for genetics in the immune response to the varicella vaccine. Pediatr Infect Dis J. 2007 Apr; 26(4):300-5.
    View in: PubMed
    Score: 0.147
  25. Safety of quadrivalent human papillomavirus vaccine administered routinely to females. Arch Pediatr Adolesc Med. 2012 Dec; 166(12):1140-8.
    View in: PubMed
    Score: 0.109
  26. Evaluation of immunization rates and safety among children with inborn errors of metabolism. Pediatrics. 2011 May; 127(5):e1139-46.
    View in: PubMed
    Score: 0.097
  27. Differential maternal responses to a newly developed vaccine information pamphlet. Vaccine. 2009 Dec 11; 28(2):323-8.
    View in: PubMed
    Score: 0.088

© 2024 Kaiser Permanente